These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 19213228)

  • 1. Stasis dermatitis as a complication of amlodipine therapy.
    Gosnell AL; Nedorost ST
    J Drugs Dermatol; 2009 Feb; 8(2):135-7. PubMed ID: 19213228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerability of high doses of lercanidipine versus high doses of other dihydropyridines in daily clinical practice: the TOLERANCE Study.
    Barrios V; Escobar C; de la Figuera M; Llisterri JL; Honorato J; Segura J; Calderón A
    Cardiovasc Ther; 2008; 26(1):2-9. PubMed ID: 18466416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Phase III, double-blind, parallel-group controlled study of amlodipine 10 mg once daily in Japanese patients with essential hypertension who insufficiently responded to amlodipine 5 mg once daily.
    Fujiwara T; Ii Y; Hatsuzawa J; Murase H; Watanabe T; Murakami M; Kimura N; Buch J; Tsuchihashi T; Saruta T
    J Hum Hypertens; 2009 Aug; 23(8):521-9. PubMed ID: 19148107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amlodipine-induced myoclonus.
    Wallace EL; Lingle K; Pierce D; Satko S
    Am J Med; 2009 Apr; 122(4):e7. PubMed ID: 19332219
    [No Abstract]   [Full Text] [Related]  

  • 5. Manidipine in hypertensive patients with metabolic syndrome: the MARIMBA study.
    Martínez Martín FJ
    Expert Rev Cardiovasc Ther; 2009 Jul; 7(7):863-9. PubMed ID: 19589122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial presentation of stasis dermatitis mimicking solitary lesions: a previously unrecognized clinical scenario.
    Weaver J; Billings SD
    J Am Acad Dermatol; 2009 Dec; 61(6):1028-32. PubMed ID: 19925928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of calcium channel blocker drugs in neuromuscular transmission.
    Ozkul Y
    Clin Neurophysiol; 2007 Sep; 118(9):2005-8. PubMed ID: 17644037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amlodipine associated hyperpigmentation.
    Erbagci Z
    Saudi Med J; 2004 Jan; 25(1):103-5. PubMed ID: 14758392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amlodipine-induced bilateral upper extremity edema.
    Ganeshalingham A; Wong W
    Ann Pharmacother; 2007 Sep; 41(9):1536-8. PubMed ID: 17666572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. International open-label studies to assess the efficacy and safety of single-pill amlodipine/atorvastatin in attaining blood pressure and lipid targets recommended by country-specific guidelines: the JEWEL programme.
    Richard Hobbs FD; Gensini G; John Mancini GB; Manolis AJ; Bauer B; Genest J; Feldman RD; Harvey P; Jenssen TG; da Silva PM;
    Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16(4):472-80. PubMed ID: 19407658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of gingival overgrowth among elderly patients under amlodipine therapy at a large Indian teaching hospital.
    Karnik R; Bhat KM; Bhat GS
    Gerodontology; 2012 Sep; 29(3):209-13. PubMed ID: 22506838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probable amlodipine-induced angioedema.
    Southward J; Irvine E; Rabinovich M
    Ann Pharmacother; 2009 Apr; 43(4):772-6. PubMed ID: 19299323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Achilles tendonitis: an unusual complication of amlodipine therapy.
    Zambanini A; Padley S; Cox A; Feher M
    J Hum Hypertens; 1999 Aug; 13(8):565-6. PubMed ID: 10455480
    [No Abstract]   [Full Text] [Related]  

  • 14. [Leukocytoclastic vasculitis in relation to amlodipine administration].
    del Río Fernández MC; Plagaro Cordero ME; de Frutos Arribas JF; del Pozo Román T; Martín Escudero JC
    Rev Clin Esp; 1995 Oct; 195(10):738-9. PubMed ID: 8532938
    [No Abstract]   [Full Text] [Related]  

  • 15. [Drug surveillance note. Telangiectasis and calcium antagonists].
    Schmutz JL; Barbaud A; Tréchot P
    Ann Dermatol Venereol; 1999; 126(6-7):546. PubMed ID: 10495872
    [No Abstract]   [Full Text] [Related]  

  • 16. Purpura and bleeding due to calcium-channel blockers: an underestimated problem? Case reports and a pilot study.
    Cox NH; Walsh ML; Robson RH
    Clin Exp Dermatol; 2009 Jun; 34(4):487-91. PubMed ID: 19094124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of force-titrated valsartan/hydrochlorothiazide versus amlodipine/hydrochlorothiazide on ambulatory blood pressure in patients with stage 2 hypertension: the EVALUATE study.
    Lacourcière Y; Wright JT; Samuel R; Zappe D; Purkayastha D; Black HR;
    Blood Press Monit; 2009 Jun; 14(3):112-20. PubMed ID: 19384192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Gingival hyperplasia associated with amlodipine].
    Infante Cossío P; Torelló Iserte J; Espín Gálvez F; García-Perla A; Rodríguez-Armijo Sánchez L; Castillo Ferrando JR
    An Med Interna; 1997 Feb; 14(2):83-5. PubMed ID: 9206519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stasis dermatitis as a complication of recurrent levofloxacin-associated bilateral leg edema.
    Hyman DA; Cohen PR
    Dermatol Online J; 2013 Nov; 19(11):20399. PubMed ID: 24314775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the antiproteinuric effects of the calcium channel blockers benidipine and amlodipine administered in combination with angiotensin receptor blockers to hypertensive patients with stage 3-5 chronic kidney disease.
    Abe M; Okada K; Maruyama T; Maruyama N; Matsumoto K
    Hypertens Res; 2009 Apr; 32(4):270-5. PubMed ID: 19262495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.